Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Alexion Pharmaceuticals Inc (ALXN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Alexion's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Alexion historical data, for real-time data please try another search
182.50 0.00    0.00%
20/07 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 180.13 - 182.67
Alexion 182.50 0.00 0.00%

ALXN Balance Sheet

 
Featured here, the Balance Sheet for Alexion Pharmaceuticals Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2021
31/03
 2020
31/12
 2020
30/09
 2020
30/06
Total Current Assets 6452.6 5833 5067.8 5367.9
Cash and Short Term Investments 3469.3 2999.4 2296.9 2851.8
Cash - - - -
Cash & Equivalents 3429.6 2964.5 2268 2825
Short Term Investments 39.7 34.9 28.9 26.8
Total Receivables, Net 1473 1409.3 1437.1 1372.2
Accounts Receivables - Trade, Net 1473 1409.3 1437.1 1372.2
Total Inventory 803.9 775.7 729 577.7
Prepaid Expenses 706.4 648.6 604.8 522.7
Other Current Assets, Total - - - 43.5
Total Assets 18650.2 18103 17548.4 16703.2
Property/Plant/Equipment, Total - Net 1461.6 1461.9 1434.6 1406.3
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 5100.1 5100.1 5100.7 5075.2
Intangibles, Net 3048.3 3002.4 3056.6 2059.7
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2587.6 2705.6 2888.7 2794.1
Other Assets, Total - - - -
Total Current Liabilities 1426.2 1624.7 1331 1120.1
Accounts Payable 125.3 118.6 89.2 -
Payable/Accrued - 1203.3 - 861.6
Accrued Expenses 910.7 1084.7 978.4 -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 143.2 142.4 138.6 126.8
Other Current liabilities, Total 247 279 124.8 131.7
Total Liabilities 6233.4 6451.8 6473.5 6212.4
Total Long Term Debt 2388.8 2419.6 2453.3 2311.6
Long Term Debt 2388.8 2419.6 2453.3 2311.6
Capital Lease Obligations - - - -
Deferred Income Tax 1639.1 1632.2 1818.2 1946.8
Minority Interest 14.2 - - -
Other Liabilities, Total 765.1 775.3 871 833.9
Total Equity 12416.8 11651.2 11074.9 10490.8
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - - - -
Additional Paid-In Capital 9243.3 9152.9 9030.4 8942.4
Retained Earnings (Accumulated Deficit) 5879.2 5243.2 4707.4 4129.3
Treasury Stock - Common -2620.5 -2620.3 -2543.7 -2470
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -85.2 -124.6 -119.2 -110.9
Total Liabilities & Shareholders' Equity 18650.2 18103 17548.4 16703.2
Total Common Shares Outstanding 220.9 219.5 219 219.1
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ALXN Comments

Write your thoughts about Alexion Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Luke Sky
Luke Sky Apr 24, 2021 1:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Give the anti-corona spray from marinomed-biotech some VC and invest in a pharma company which is heading to the moon:https://www.investing.com/equities/marinomed-biotech-agStudies are proving that the patented method of marinomed prevents infection with all Corona varietis including mutants. It also prevents other virus infections. They have many patents.  Do some good and get rich
Reply
2 1
Report
Raul AlKhuwaitem
Raul AlKhuwaitem Dec 15, 2020 8:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ATVI, Nio, Li and Fcel will be very good shares to buy and hold.. 30% to 60% gain gradually soon..
Reply
2 1
Report
Candy Man
Candy Man Dec 14, 2020 1:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Currently this should trading st about 166-167, due to the buyout. Seems like market here is off by in ballbark of 10.
Reply
0 0
Report
Gerard Oliva
Gerard Oliva Dec 14, 2020 1:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
market is pricing risk of deal not going through, thats why astrazenca plummeted today
Reply
0 0
Report
Candy Man
Candy Man Dec 14, 2020 1:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ok, ty, i thought as much
Reply
0 0
Report
Jeremie Lachance
Jeremie Lachance Dec 14, 2020 1:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Gerard Oliva  Even if the deal doesn't go throught, alexion is still a compagny to buy
Reply
1 0
Report
Candy Man
Candy Man Dec 14, 2020 12:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Shouldnt it be trading at around 167 atm. ?
Reply
0 0
Report
Show previous replies (7)
rany mishal
rany mishal Dec 14, 2020 12:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Candy Man  i was closer with 178 xd
Reply
0 0
Report
Candy Man
Candy Man Dec 14, 2020 12:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
AZN trading at 50.5$, this roughly translates into 166$, about some 8$ off.
Reply
0 0
Report
rany mishal
rany mishal Dec 14, 2020 12:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Candy Man  AZN?
Reply
0 0
Report
Candy Man
Candy Man Dec 14, 2020 12:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Astrazeneca
Reply
0 0
Report
rany mishal
rany mishal Dec 14, 2020 12:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Candy Man  Ya brain farted lol, was having lunch
Reply
0 0
Report
rany mishal
rany mishal Dec 14, 2020 11:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
still needs to go to atleast177 to represent the new marketcap of 39 bill after the sale.
Reply
0 0
Report
Raul AlKhuwaitem
Raul AlKhuwaitem Dec 14, 2020 11:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
TUSK double the price very soon..Very low volume.. Easy to jump.. Don't miss it.. Good luck guys..
Reply
2 1
Report
lee doloff
lee doloff Dec 14, 2020 5:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
why is this stock rising if it was sold
Reply
2 1
Report
Erik Kraft
Erik Kraft Dec 14, 2020 5:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Astra buys Alexion for a share price of $175
Reply
1 0
Report
Juice Leskinen
Juice Leskinen Dec 14, 2020 5:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
only 60 is money rest AZN shares. Deal can go bust also and AZN share price is down 5pros so pris is buying price is down like 3pros. If deal goes sauer Alexion will go under original price fast and hard.
Reply
0 0
Report
Gadam Hudayberdi
Gadam Hudayberdi Dec 12, 2020 8:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
AstraZeneca is buying this, what is next? (read article)
Reply
0 0
Report
Ryan Chatton
Ryan Chatton Dec 12, 2020 8:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Long tp 165
Reply
0 0
Report
Erik Kraft
Erik Kraft Dec 12, 2020 8:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
they buy it at share price around 175$, shareholders get AstraZeneca shares and a premium too
Reply
0 0
Report
Marco Garrido
Marco Garrido Nov 25, 2020 12:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Cocrystal Pharma, Inc. (COCP), up 45%
Reply
0 0
Report
LWH LWH
LWH LWH Aug 05, 2020 12:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
seems extremely undervalued and yet no takers? can anyone explain?
Reply
0 1
Report
John Moris
John Moris Aug 05, 2020 12:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
if you check the historical fundamentals I agree, it seems to be very undervalued. BUT the earnings depends strongly of a very expensive drug for a rare disease and concurrents have fund a less expensive efficacious drug for the same disease.
Reply
5 3
Report
Zami Azm
Zami Azm Aug 05, 2020 12:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You were right. Its 31 aug today and the price just increased by alot.
Reply
1 2
Report
Alex Pol
Alex Pol Aug 05, 2020 12:04PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Waiting for low $90s, may be another shot there. It's not about what you think is undervalued, it's about what market thinks.
Reply
1 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email